Variant report

Variant	esv1822121
Chromosome Location	chr5:80255984-80257109
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:171)
CpG islands
(count:552)
Chromatin interactive
region (count:0)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:171 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:80255588-80256100	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL3	chr5:80255146-80256092	GM12878	blood:	n/a	n/a
3	CHD1	chr5:80256711-80256898	H1-hESC	embryonic stem cell:	n/a	n/a
4	CREB1	chr5:80256401-80256642	A549	lung:	n/a	n/a
5	CREB1	chr5:80255584-80257085	HepG2	liver:	n/a	n/a
6	CTBP2	chr5:80255809-80257416	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr5:80256360-80256510	HRE	kidney:	n/a	n/a
8	CTCF	chr5:80256767-80256768	A549	lung:	n/a	n/a
9	CTCF	chr5:80256620-80256770	GM12866	blood:	n/a	n/a
10	CTCF	chr5:80256858-80256922	GM13976	blood:	n/a	n/a
11	CTCF	chr5:80256354-80256560	GM19238	blood:	n/a	n/a
12	CTCF	chr5:80256241-80256615	HepG2	liver:	n/a	n/a
13	CTCF	chr5:80256260-80256410	GM12869	blood:	n/a	n/a
14	CTCF	chr5:80256420-80256570	GM12875	blood:	n/a	n/a
15	CTCF	chr5:80256380-80256530	HAc	cerebellar:	n/a	n/a
16	CTCF	chr5:80256360-80256510	HFF	foreskin:	n/a	n/a
17	CTCF	chr5:80256580-80256730	BJ	skin:	n/a	n/a
18	CTCF	chr5:80256360-80256510	SAEC	small airway:	n/a	n/a
19	CTCF	chr5:80256460-80256610	HVMF	connective:	n/a	n/a
20	CTCF	chr5:80256340-80256490	HRPEpiC	eye:	n/a	n/a
21	CTCF	chr5:80256362-80256571	ProgFib	skin:	n/a	n/a
22	CTCF	chr5:80256420-80256570	HBMEC	blood vessel:	n/a	n/a
23	CTCF	chr5:80256330-80256537	HepG2	liver:	n/a	n/a
24	CTCF	chr5:80256391-80256503	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr5:80256300-80256450	HRPEpiC	eye:	n/a	n/a
26	CTCF	chr5:80256320-80256470	GM12866	blood:	n/a	n/a
27	CTCF	chr5:80256368-80256591	Fibrobl	skin:	n/a	n/a
28	CTCF	chr5:80256425-80256471	Pancreas_OC	pancreas:	n/a	n/a
29	CTCF	chr5:80256380-80256530	GM12873	blood:	n/a	n/a
30	CTCF	chr5:80256400-80256550	HUVEC	blood vessel:	n/a	n/a
31	CTCF	chr5:80256395-80256520	GM19240	blood:	n/a	n/a
32	CTCF	chr5:80256681-80256774	GM12891	blood:	n/a	n/a
33	CTCF	chr5:80256040-80256190	SAEC	small airway:	n/a	n/a
34	CTCF	chr5:80256285-80256655	IMR90	lung:	n/a	n/a
35	CTCF	chr5:80256380-80256530	GM12871	blood:	n/a	n/a
36	CTCF	chr5:80256340-80256490	GM12870	blood:	n/a	n/a
37	CTCF	chr5:80256720-80256870	HCPEpiC	choroid plexus:	n/a	n/a
38	CTCF	chr5:80256400-80256550	GM12872	blood:	n/a	n/a
39	CTCF	chr5:80256340-80256490	GM12867	blood:	n/a	n/a
40	CTCF	chr5:80256360-80256510	A549	lung:	n/a	n/a
41	CTCF	chr5:80256360-80256510	HCM	heart:	n/a	n/a
42	CTCF	chr5:80256351-80256519	Kidney_OC	kidney:	n/a	n/a
43	CTCF	chr5:80256720-80256870	AG04449	skin:	n/a	n/a
44	CTCF	chr5:80256400-80256550	AG04449	skin:	n/a	n/a
45	CTCF	chr5:80256020-80256170	GM12871	blood:	n/a	n/a
46	CTCF	chr5:80256351-80256519	Spleen_OC	spleen:	n/a	n/a
47	CTCF	chr5:80256342-80256484	SK-N-SH_RA	brain:	n/a	n/a
48	CTCF	chr5:80256388-80256490	GM13977	blood:	n/a	n/a
49	CTCF	chr5:80256360-80256510	AG04450	lung:	n/a	n/a
50	CTCF	chr5:80256320-80256470	AoAF	blood vessel:	n/a	n/a

(count:552 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:80256664-80256714	MCF-7	breast:	n/a
2	chr5:80256535-80256585	AG10803	skin:	n/a
3	chr5:80256371-80256421	K562	blood:	n/a
4	chr5:80256664-80256714	MCF-7	breast:	n/a
5	chr5:80256535-80256585	AG10803	skin:	n/a
6	chr5:80256371-80256421	K562	blood:	n/a
7	chr5:80256524-80256574	IMR90	lung:	fetal
8	chr5:80256371-80256421	Caco-2	colon:	n/a
9	chr5:80256971-80257021	HEK293	kidney:	embryo
10	chr5:80256738-80256788	Hepatocyte	liver:	n/a
11	chr5:80256971-80257021	IMR90	lung:	fetal
12	chr5:80256371-80256421	HNPCEpiC	eye:	n/a
13	chr5:80256137-80256187	LNCaP	prostate:	n/a
14	chr5:80256524-80256574	HEK293	kidney:	embryo
15	chr5:80256524-80256574	SK-N-MC	brain:	n/a
16	chr5:80256166-80256216	GM12891	blood:	n/a
17	chr5:80256738-80256788	AoSMC	blood vessel:	n/a
18	chr5:80256087-80256137	AG09319	gingival:	n/a
19	chr5:80256524-80256574	AG09319	gingival:	n/a
20	chr5:80256371-80256421	HepG2	liver:	n/a
21	chr5:80256524-80256574	MCF10A-Er-Src	breast:	n/a
22	chr5:80256535-80256585	K562	blood:	n/a
23	chr5:80256971-80257021	GM12891	blood:	n/a
24	chr5:80256166-80256216	AG10803	skin:	n/a
25	chr5:80256971-80257021	HRE	kidney:	n/a
26	chr5:80256524-80256574	PFSK-1	brain:	n/a
27	chr5:80256166-80256216	ECC-1	luminal epithelium:	n/a
28	chr5:80256137-80256187	AG04449	skin:	fetal
29	chr5:80256371-80256421	HCT-116	colon:	n/a
30	chr5:80256137-80256187	BJ	skin:	n/a
31	chr5:80256535-80256585	HMEC	breast:	n/a
32	chr5:80256087-80256137	HepG2	liver:	n/a
33	chr5:80256371-80256421	T-47D	breast:	n/a
34	chr5:80256664-80256714	HCM	heart:	n/a
35	chr5:80256535-80256585	MCF10A-Er-Src	breast:	n/a
36	chr5:80256137-80256187	K562	blood:	n/a
37	chr5:80256535-80256585	HRE	kidney:	n/a
38	chr5:80256371-80256421	AG04449	skin:	fetal
39	chr5:80256664-80256714	BE2_C	brain:	n/a
40	chr5:80256137-80256187	NB4	blood:	n/a
41	chr5:80256166-80256216	PANC-1	pancreas:	n/a
42	chr5:80256971-80257021	HepG2	liver:	n/a
43	chr5:80256087-80256137	GM12891	blood:	n/a
44	chr5:80256738-80256788	HMEC	breast:	n/a
45	chr5:80256738-80256788	SKMC	muscle:	n/a
46	chr5:80256664-80256714	AG09319	gingival:	n/a
47	chr5:80256371-80256421	NT2-D1	testis:	n/a
48	chr5:80256664-80256714	HepG2	liver:	n/a
49	chr5:80256535-80256585	HEK293	kidney:	embryo
50	chr5:80256371-80256421	AG10803	skin:	n/a

No data

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHFR-2	chr5:80256600-80256726	NR_105015
2	lnc-DHFR-2	chr5:80256600-80256726	ENSG00000251450.1
3	lnc-DHFR-2	chr5:80256150-80256189	XLOC_004907

No data

Variant related genes	Relation type
ENSG00000251450	TF binding region
RASGRF2	TF binding region
ENSG00000251450	CpG island
RASGRF2	CpG island
CLSTN1	miRNA target sites

Extended variants
information (count: 48 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:48 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567381181	chr5:80255996-80255997	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs536372664	chr5:80256053-80256054	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs552966695	chr5:80256066-80256067	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs566480555	chr5:80256163-80256164	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs535335752	chr5:80256164-80256165	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs113829217	chr5:80256270-80256271	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs113077126	chr5:80256294-80256295	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs139949554	chr5:80256299-80256300	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs557294649	chr5:80256312-80256313	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs73123076	chr5:80256339-80256340	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs542721215	chr5:80256380-80256381	Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs553018509	chr5:80256410-80256411	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs559273802	chr5:80256422-80256423	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs375975609	chr5:80256443-80256444	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs368584906	chr5:80256484-80256485	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs374422363	chr5:80256507-80256508	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs199546647	chr5:80256594-80256595	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs114321099	chr5:80256596-80256597	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs188573830	chr5:80256614-80256615	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
20	rs373681724	chr5:80256623-80256624	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
21	rs377311539	chr5:80256626-80256627	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
22	rs148129112	chr5:80256663-80256664	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
23	rs367826821	chr5:80256707-80256708	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	lncRNA	n/a	Overlapped CNVs	n/a
24	rs560703743	chr5:80256728-80256729	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs369507058	chr5:80256743-80256744	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs35472385	chr5:80256771-80256772	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs192968774	chr5:80256785-80256786	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs546766609	chr5:80256789-80256790	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs377116128	chr5:80256791-80256792	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs548661375	chr5:80256901-80256902	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs538663799	chr5:80256902-80256903	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs558146671	chr5:80256907-80256908	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs888821	chr5:80256909-80256910	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs537361706	chr5:80256915-80256916	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs79296318	chr5:80256933-80256934	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs557488948	chr5:80256946-80256947	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs534886581	chr5:80256955-80256956	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs200904270	chr5:80256959-80256960	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs143632743	chr5:80256964-80256965	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs374890458	chr5:80256967-80256968	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs888820	chr5:80256973-80256974	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs572883665	chr5:80256996-80256997	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs545411135	chr5:80257005-80257006	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
44	rs565155772	chr5:80257037-80257038	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs575459092	chr5:80257048-80257049	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs78642142	chr5:80257055-80257056	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs561061274	chr5:80257080-80257081	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs888819	chr5:80257109-80257110	Bivalent/Poised TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:79)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	21251322	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Myelofibrosis	22110671	CNVD
craniofacial dysmorphism	21918468	CNVD
lymphocytic leukemia	21291569	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD

Chromatin state (count:292 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:80253200-80256000	Bivalent Enhancer	Fetal Thymus	thymus
2	chr5:80255000-80256000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
3	chr5:80255000-80256000	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
4	chr5:80255200-80256000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
5	chr5:80255200-80256000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr5:80255200-80256000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
7	chr5:80255200-80256000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
8	chr5:80255200-80256000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
9	chr5:80255200-80256600	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
10	chr5:80255400-80256000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
11	chr5:80255400-80256000	Bivalent/Poised TSS	Primary B cells from cord blood	blood
12	chr5:80255400-80256000	Flanking Active TSS	Primary T cells fromperipheralblood	blood
13	chr5:80255400-80256000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
14	chr5:80255400-80256000	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
15	chr5:80255400-80256000	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
16	chr5:80255400-80256000	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
17	chr5:80255400-80256000	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
18	chr5:80255400-80256000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
19	chr5:80255400-80256000	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
20	chr5:80255400-80256000	Flanking Bivalent TSS/Enh	NHDF-Ad	bronchial
21	chr5:80255400-80257400	Active TSS	Colon Smooth Muscle	Colon
22	chr5:80255600-80256000	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr5:80255600-80256000	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr5:80255600-80256000	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
26	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
27	chr5:80255600-80256000	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
28	chr5:80255600-80256000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
29	chr5:80255600-80256000	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
30	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Muscle Satellite Cultured Cells	--
31	chr5:80255600-80256000	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
32	chr5:80255600-80256000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
33	chr5:80255600-80256000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
35	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Fetal Brain Male	brain
36	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
37	chr5:80255600-80256000	Bivalent/Poised TSS	Pancreatic Islets	Pancreatic Islet
38	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Fetal Lung	lung
39	chr5:80255600-80256000	Bivalent Enhancer	Placenta	Placenta
40	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Left Ventricle	heart
41	chr5:80255600-80256000	Bivalent Enhancer	Lung	lung
42	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
43	chr5:80255600-80256000	Flanking Active TSS	HepG2	liver
44	chr5:80255600-80256000	Flanking Bivalent TSS/Enh	HUVEC	blood vessel
45	chr5:80255600-80256200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
46	chr5:80255600-80256200	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr5:80255600-80256200	Flanking Bivalent TSS/Enh	Primary mononuclear cells fromperipheralblood	Blood
48	chr5:80255600-80256200	Flanking Bivalent TSS/Enh	Right Ventricle	heart
49	chr5:80255600-80256600	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr5:80255600-80256800	Active TSS	Primary T regulatory cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links